Abaxis Gets Warning Letter for Adulterated Potassium Diagnostic

The GMP Letter
A A
Abaxis was hit with an FDA warning letter over changes it made to a potassium assay used with its chemistry analyzer device that caused the product to be adulterated and misbranded.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00